Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells.
- Author:
Chun-liang LEI
1
;
Cheng-hui HUANG
;
Zhan YANG
;
Xiao-ping TANG
Author Information
- Publication Type:Journal Article
- MeSH: Cell Line; Cells, Cultured; Cytotoxicity, Immunologic; Dendritic Cells; immunology; virology; Hepatitis B; immunology; virology; Hepatitis B Surface Antigens; genetics; immunology; Hepatitis B virus; genetics; immunology; Humans; Lymphocyte Culture Test, Mixed; T-Lymphocytes, Cytotoxic; immunology
- From: Chinese Journal of Experimental and Clinical Virology 2007;21(2):108-110
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore whether hepatitis B virus (HBV) S gene-modified dendritic cells (DCs) might induce a specific cytotoxic T lymphocyte (CTL) response.
METHODSThe recombinant adenoviruses carrying HBsAg genes were prepared and used to transfect DCs generated from cord blood. The efficacy of transfection was observed through the expression of enhanced green fluorescent protein (EGFP) in DCs and the expression of HBsAg was detected by ELISA. HBV S gene-modified DCs were co-cultured with T cells from cord blood and T cells stimulating activities were detected using mixed lymphocyte reaction (MLR). The CTL assay was carried out to assess the ability of CTL lines to lyse target cells of HepG(2)22.1.5 by measuring lactate dehydrogenase (LDH) release.
RESULTSThe results showed that HBV S genes were expressed in DCs with high efficacy by recombinant adenoviral vector. DCs had a normal shape after transfection. The result of MLR showed that HBV S gene-modified DCs could effectively stimulate naive T cells to proliferate. The induced specific CTL lines could lyse target cells of HepG(2)22.1.5.
CONCLUSIONSHBV S gene-modified DCs enhanced the function to induce a specific CTL effect, showing its promise for developing anti-viral vaccine in future.
